SCHEMBL7528699

SCHEMBL7528699

C=CC(=O)NCCOCCOCCOC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZDHHC20 Q5W0Z9 1/20 0.46
ZDHHC2 Q9UIJ5 1/20 0.46
TSHR P16473 4/20 0.43
ALDH1A1 P00352 4/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 2/20 0.39
HIF1A Q16665 2/20 0.39
HSD17B10 Q99714 1/20 0.39
GLA P06280 2/20 0.38
HPGD P15428 1/20 0.38
TGM2 P21980 2/20 0.35
KDM4E B2RXH2 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PYGL P06737 1/20 0.35
EPHX2 P34913 2/20 0.35
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29519145 1.00 ZDHHC20 (0.46) ZDHHC20ZDHHC2TSHRALDH1A1MAPK1
SCHEMBL29519271 1.00 ZDHHC20 (0.46) ZDHHC20ZDHHC2TSHRALDH1A1MAPK1
SCHEMBL29519122 1.00 ZDHHC20 (0.46) ZDHHC20ZDHHC2TSHRALDH1A1MAPK1
SCHEMBL17107298 1.00 ZDHHC20 (0.46) ZDHHC20ZDHHC2TSHRALDH1A1MAPK1
SCHEMBL29519312 1.00 ZDHHC20 (0.46) ZDHHC20ZDHHC2TSHRALDH1A1MAPK1
SCHEMBL4849233 1.00 ZDHHC20 (0.46) ZDHHC20ZDHHC2TSHRALDH1A1MAPK1
SCHEMBL12328384 0.90 TSHR (0.52) ZDHHC20ZDHHC2TSHRALDH1A1MAPK1
SCHEMBL12213321 0.90 TSHR (0.52) ZDHHC20ZDHHC2TSHRALDH1A1MAPK1
SCHEMBL4361183 0.90 TSHR (0.52) ZDHHC20ZDHHC2TSHRALDH1A1MAPK1
SCHEMBL12328966 0.90 TSHR (0.52) ZDHHC20ZDHHC2TSHRALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024112744-A1 CATALYSTS AND METHODS OF USE THEREOF YALE UNIVERSITY (US) 2024-05-30 WO disclosed
EP-4349922-A1 OIL-RESISTANT AGENT COMPOSITION DAIKIN INDUSTRIES, LTD. (JP) 2024-04-10 EP disclosed
US-10226544-B2 Malodor counteracting compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2019-03-12 US disclosed
EP-3123542-B1 GEL ELECTROLYTES AND ELECTRODES BASF SE (DE) 2018-01-10 EP disclosed
US-9755268-B2 Gel electrolytes and electrodes SION POWER CORPORATION (US) 2017-09-05 US disclosed
US-9755268-B2 Gel electrolytes and electrodes SION POWER CORPORATION (US) 2017-09-05 US disclosed
US-9755268-B2 Gel electrolytes and electrodes SION POWER CORPORATION (US) 2017-09-05 US disclosed
EP-3123542-A1 GEL ELECTROLYTES AND ELECTRODES BASF SE (DE) 2017-02-01 EP disclosed
US-20150280277-A1 GEL ELECTROLYTES AND ELECTRODES SION POWER CORPORATION (US) 2015-10-01 US disclosed
US-20150280277-A1 GEL ELECTROLYTES AND ELECTRODES SION POWER CORPORATION (US) 2015-10-01 US disclosed
US-20150280277-A1 GEL ELECTROLYTES AND ELECTRODES SION POWER CORPORATION (US) 2015-10-01 US disclosed
US-20020022585-A1 Detergent compositions with improved whitening benefits and methods and articles employing same THE PROCTER & GAMBLE COMPANY 2002-02-21 US disclosed
WO-2001092451-A1 DETERGENT COMPOSITIONS AND METHODS AND ARTICLES EMPLOYING SAME THE PROCTER & GAMBLE COMPANY (US) 2001-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10226544-B2 Malodor counteracting compositions LPO, MAL2, ME1 ZDHHC20 2100/4885ZDHHC2 2354/4885TSHR 3282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.